Epilepsy medicine worry

Otago Daily Times

24 June 2019 - A controversial change of epilepsy drug funding could see her and thousands of other people with epilepsy lose their quality of life and livelihoods, Brighton massage therapist Jemima Pedro-Davison fears.

Government drug-buying agency PHARMAC recently opted to change its funding from a range of lamotrigine epilepsy medications to just a single brand, Logem.

About 45,000 New Zealanders have epilepsy, and their national organisation Epilepsy New Zealand is deeply concerned that proven effective drug Lamictal will no longer be funded.

Read Otago Daily Times article

Michael Wonder

Posted by:

Michael Wonder